EP 2139509 A2 20100106 - TREATMENT OF AUTOIMMUNE DISORDERS
Title (en)
TREATMENT OF AUTOIMMUNE DISORDERS
Title (de)
BEHANDLUNG VON AUTOIMMUNKRANKHEITEN
Title (fr)
TRAITEMENT DE TROUBLES AUTO-IMMUNS
Publication
Application
Priority
- US 2008003548 W 20080317
- US 91851807 P 20070315
Abstract (en)
[origin: WO2008112325A2] Methods of treating disease with soluble inhibitors of the lymphotoxin pathway having improved properties. Improved LTBR-Ig fusion proteins, and pharmaceutical compositions thereof, are also described.
IPC 8 full level
C07K 14/715 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 19/02 (2017.12); A61P 29/00 (2017.12); A61P 37/00 (2017.12); A61P 37/02 (2017.12); C07K 14/7151 (2013.01); C12N 15/62 (2013.01); A61K 38/00 (2013.01); C07K 2319/30 (2013.01)
Citation (search report)
See references of WO 2008112325A2
Citation (examination)
- WO 2008049053 A2 20080424 - BIOGEN IDEC INC [US], et al
- WO 2009111347 A1 20090911 - BIOGEN IDEC INC [US], et al
- WO 2008143954 A2 20081127 - BIOGEN IDEC INC [US], et al
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
WO 2008112325 A2 20080918; WO 2008112325 A3 20091223; CA 2680792 A1 20080918; CN 101951940 A 20110119; EP 2139509 A2 20100106; JP 2010521472 A 20100624; JP 5431171 B2 20140305
DOCDB simple family (application)
US 2008003548 W 20080317; CA 2680792 A 20080317; CN 200880016341 A 20080317; EP 08742126 A 20080317; JP 2009553656 A 20080317